Effects of anti-inflammatory dietary education on sleep disturbances among patients with breast cancer undergoing chemotherapy: A randomized controlled trial.

Authors

Lan Cheng, Zhenzhen Huang, Jianyun He, Xinxin Cheng, Yuting Wang, Xiaoxia Lin, Xinyi Miao, Ran Wang, Shufang Xia

Published in

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Volume 34. Issue 11. Oct 10, 2026. Epub Oct 10, 2026.

Abstract

This randomized controlled trial evaluated the effects of anti-inflammatory dietary education on sleep disturbances and inflammatory biomarkers in patients with breast cancer undergoing chemotherapy.
A total of 132 patients with sleep disturbances were randomized to receive either a 12-week anti-inflammatory dietary education program based on the energy-adjusted dietary inflammatory index (E-DII) or usual care. Sleep disturbances were assessed using the Pittsburgh Sleep Quality Index (PSQI) at baseline and at 12 weeks. Additional outcomes included inflammatory biomarkers, E-DII scores, and quality of life (QoL). Treatment effects on continuous outcomes were evaluated using linear mixed-effects models (LMMs) under the intention-to-treat principle. The proportions of participants with sleep disturbance (PSQI ≥ 8) at 12 weeks were compared between groups using a completer analysis.
Of the 132 participants, 116 (87.9%) completed the 12-week assessment. In the completer analysis, the proportion of participants with sleep disturbance at 12 weeks was significantly lower in the intervention group than in the control group (49.2% vs. 78.9%, P < 0.001). The intervention group demonstrated greater reductions in PSQI (β =  - 2.10; 95% CI: - 3.01, - 1.18; P < 0.001) and E-DII scores (β =  - 1.23; 95% CI: - 1.98, - 0.47; P = 0.002) and improved overall QoL (β = 14.07; 95% CI: 8.61, 19.52; P < 0.001). Furthermore, levels of interleukin-1β, interleukin-6, and C-reactive protein were significantly reduced, whereas interleukin-10 increased (all P < 0.05).
Anti-inflammatory dietary education reduced sleep disturbances and improved QoL in patients with breast cancer undergoing chemotherapy and was accompanied by favorable changes in inflammatory biomarkers.
ChiCTR2500097053. Registered on 11 February 2025.

PMID:
42859245
Bibliographic data and abstract were imported from PubMed on 11 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.